Latest NewsApr 19, 2018

Orgenesis Reports 42% Increase in Revenue for the First Quarter of Fiscal 2018

Recent News

Mar 19, 2018
MaSTherCell Appointed as Process Development and Manufacturing Partner for Zelluna Immunotherapy’s TCR Adoptive Cell Therapy Platform
Mar 12, 2018
Orgenesis Announces Listing on NASDAQ Capital Market
Mar 5, 2018
Orgenesis Reports 78% Increase in Revenue for the Fourth Quarter of Fiscal 2017
Feb 6, 2018
Orgenesis and Adva Biotechnology to Develop and Distribute Advanced Automated Culturing System for Cell Therapy Manufacturing
View All Press Releases

Latest EventJan 30, 2018 • 3:00pm EDT

NobleCon 14th Annual Institutional Investor Conference
View All Events